MARKET

JNCE

Jounce Therapeutics Inc
JNCE
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-7.2075
3.489
0.5307
98,954,679.84
Atea Pharmaceuticals Surges Over on Potential Takeover Bid
TipRanks · 05/22/2023 19:42
United Therapeutics (UTHR) Q1 Earnings Beat, Sales Miss
NASDAQ · 05/04/2023 13:04
Press Release: Jounce Therapeutics Announces Closing of Tender Offer
Dow Jones · 05/04/2023 00:35
Jounce Acquisition: Exploring Whether It Is Worth It To Pay Up For CVR Value
Seeking Alpha · 04/18/2023 20:26
Zacks Industry Outlook Highlights Catalyst Pharmaceuticals, KalVista Pharmaceuticals, Larimar Therapeutics, Nektar Therapeutics and Jounce Therapeutics
NASDAQ · 04/11/2023 12:57
5 Stocks to Buy as the Drug Industry Rebounds in 2023
NASDAQ · 04/10/2023 14:07
Jounce Therapeutics To End Proposed Business Combination With Redx Pharma Following Takeover Offer From Concentra Biosciences
Benzinga · 04/03/2023 07:42
BRIEF-Jounce Therapeutics Terminates Proposed Deal With RedX Pharma
Reuters · 04/03/2023 06:34
More

Webull offers Jounce Therapeutics Inc stock information, including NASDAQ: JNCE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JNCE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading JNCE stock methods without spending real money on the virtual paper trading platform.